EnGeneIC’s Covid-19 vaccine offers protection against variants in trials
Increased neutralising antibody levels against all variants, including Omicron BA2, and memory response were observed in subjects.
News
Latest in
News
Overcoming obstacles in trans and nonbinary participation in clinical trials
The clinical trials sector can make small changes to make transgender, nonbinary individuals feel safe to join studies.
By
Ceruvia’s Phase II obsessive-compulsive disorder trial receives FDA clearance
Analysing the decline in OCD symptoms for up to 12 weeks following a single dose of SYNP-101 is the trial’s…
Kiora gets approval to begin Phase Ib retinitis pigmentosa trial
The open-label, first-in-human, single ascending dose trial will analyse KIO-301 in individuals with retinitis pigmentosa.
Kezar reports positive Phase II data of zetomipzomib for lupus nephritis
In the trial, 64.7% of the trial subjects attained an ORR, which is the primary efficacy endpoint of the study.
Medidata introduces new technologies for trial management
Visual Analytics for Rave CTMS aids users to swiftly navigate, search and merge data using intuitive visuals, charts and tables.
Prestige Biopharma receives FDA approval for Phase I/IIa pancreatic cancer trial
PBP1510 received Orphan Drug Designation from the FDA, the European Medicines Agency and Korean MFDS, in 2020.
Otsuka, Lundbeck report positive data from Phase III Alzheimer’s trial
The CMAI total score in brexpiprazole group was statistically higher than for those receiving placebo.